Skip to content
Search

Latest Stories

34 products added to DND list

The Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA) have added a further 34 new products to the list of ‘Drugs for which Discount is Not Deducted’ (DND).

From April 2022, the discount deduction scale will no longer apply to prescriptions dispensed for the following products (split into Individual Items and Group Items):Part II (Drugs for which discount is not deducted or DND) Additions – Individual Items


  • Aldara 5% cream 250mg sachets
  • Famvir 125mg tablets
  • GlucoRx Aidex Sensor
  • Phosphates enema (Formula B) 128ml standard tube
  • Sancuso 3.1mg/24hours transdermal patches

Part II (Drugs for which discount is not deducted (DND)) Additions – Group Items

(Note: DND status was retrospectively applied to the following Group Items from March 2022)

  • Amiodarone 50mg/5ml oral suspension
  • Azathioprine 50mg/5ml oral solution
  • Chlorothiazide 150mg/5ml oral suspension
  • Chlorothiazide 25mg/5ml oral suspension
  • Co-careldopa 12.5mg/50mg/5ml oral suspension
  • Co-careldopa 25mg/100mg/5ml oral suspension
  • Diazoxide 250mg/5ml oral suspension
  • Diazoxide 50mg/5ml oral suspension
  • Fludrocortisone 100micrograms/5ml oral suspension
  • Gabapentin 100mg/5ml oral solution
  • Gabapentin 100mg/5ml oral suspension
  • Lansoprazole 15mg/5ml oral suspension
  • Lansoprazole 30mg/5ml oral suspension
  • Lansoprazole 5mg/5ml oral suspension
  • Lorazepam 1mg/5ml oral solution
  • Lorazepam 500micrograms/5ml oral solution
  • Losartan 50mg/5ml oral suspension
  • Menadiol 5mg/5ml oral suspension
  • Mercaptamine 0.55% eye drops preservative free
  • Olanzapine 2.5mg/5ml oral suspension
  • Omeprazole 40mg/5ml oral suspension
  • Omeprazole 5mg/5ml oral suspension
  • Phenobarbital 25mg/5ml oral solution
  • Phenobarbital 25mg/5ml oral suspension
  • Quetiapine 25mg/5ml oral suspension
  • Quetiapine 50mg/5ml oral suspension
  • Tetrabenazine 12.5mg/5ml oral suspension
  • Zopiclone 3.75mg/5ml oral suspension
  • Zopiclone 7.5mg/5ml oral suspension

For a list of all the monthly changes to the DND status of products please see the following page Notice of changes to discount not deducted (DND) status of products. A total of 485 products have been granted DND status following checks made by PSNC within the past 20 months.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less